3-Nitrotyrosine (3NT) is used as a biomarker of nitrative pathology caused
by peroxynitrite (PN), myeloperoxidase (MPO)-, and/or eosinophil peroxidase
(EPO)- dependent nitrite oxidation. 3NT measurements in biological materia
ls are usually based on either antibody staining, HPLC detection, or GC det
ection methodologies. In this report, a procedure is described for the meas
urement of 3NT and tyrosine (TYR) by LC-MS/MS that is simple, direct, and s
ensitive. Though highly specialized in its use as an assay, LC-MS/MS techno
logy is available in many research centers in academia and industry. The cr
itical assay for 3NT was linear below 100 ng/ml and the limit of detection
was below 100 pg/ml. Regarding protein digested samples, we found that MRM
was most selective with 133.1 m/z as the daughter ion. In comparison, LC-EC
D was 100 times less sensitive. Basal levels of 3NT in extracted digests of
rat brain homogenate were easily detected by LC-MS/MS, but were below dete
ction by LC-ECD. The LC-MS/MS assay was used to detect 3NT in rat brain hom
ogenate that was filtered through a 180 micron nylon mesh. Three fractions
were collected and examined by phase contrast microscopy. The mass ratio (3
NT/TYR) of 3NT in fractions of large vessel enrichment, microvessel enrichm
ent, and vessel depletion was 0.6 ng/mg, 1.2 ng/mg, and 0.2 ng/mg, respecti
vely. Ultimately, we found that the basal 3NT/TYR mass ratio as determined
by LC-MS/MS was six times greater in microvessel-enriched brain tissue vs.
tissue devoid of microvessels. (C) 2000 Elsevier Science Inc.